Efficacy of intradermal vaccination.
Intradermal (ID) inoculation has been investigated as a means of vaccinating laboratory animals, domestic farm animals, and humans. Various forms of viral, bacterial, parasitic, and fungal antigens have been administered ID, with varying results. This review emphasizes results from studies reporting clinically relevant outcomes such as clinical protection and body weight change following experimental challenge. Antibody titers, cytokines, cellular responses are included as supportive data. Based on the reports reviewed, ID vaccination is a promising alternative to more traditional routes of vaccination. ID vaccination has particular appeal to the beef cattle industry based on recently emphasized quality assurance issues. It is evident that the ultimate test of vaccine efficacy is the ability to protect against clinical disease under natural challenge conditions. We propose that the immune response of ID vaccinated cattle, using clinically relevant outcomes such as morbidity, mortality, average daily gain and feed efficiency, needs to be further investigated to define the value of this potentially effective and practical means of antigen delivery, particularly for domesticated farm animals.
Hunsaker
B D
BD
Schering-Plough Animal Health, Rt. 1 Box 68, Claude, TX 79019, USA. 105013.1153@compuserve.com
Perino
L J
LJ
D000822:Animal Husbandry / Q000592:standards*; D000818:Animals; D000917:Antibody Formation; D007271:Injections, Intradermal / Q000662:veterinary*; D008460:Meat / Q000592:standards; D011786:Quality Control; D014611:Vaccination / Q000662:veterinary*